Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Breast milk viscosity refers to the measure of how resistant human breast milk is to flowing. It varies widely among individuals and even within the same individual over time due to changes in fat content and other compositional factors such as casein micelles. The mean reported value ranges from approximately 18–91 centipoise (cP), with an average around 45 cP at room temperature—higher than most infant formulas tested under similar conditions. Viscosity can be influenced by maternal diet, stage of lactation, time since last feeding session, and addition of sweetening agents when comparing formulae. While not itself a druggable target or biomolecule involved in signal transduction or disease pathways directly, its variation may have practical implications for infant nutrition studies and possibly dental health outcomes due to its effect on how long sugars remain adhered within the oral cavity after feeding.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Breast milk viscosity (null).